MarketPeel
Pricing
…
JD

John Patrick Darby

EHC
EVP, GEN COUNSEL & SECRETARY · ENCOMPASS HEALTH CORP · CIK 0001664699
FILING MIX · LIFETIME40%/60%
BUYS
21
SELLS
32
TOTAL VALUE
$9.81M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
75,041
AVG SELL PX
$92.77
TRADE KIND
SHOWING 53 / 53
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by John Patrick Darby, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+1.47%+0.82%+0.64%+0.64%—
14d2+0.00%+1.68%+4.24%-2.56%-2.56%—
30d2+0.00%+2.66%+4.97%-2.32%-2.32%—
60d2+0.00%+3.15%+9.32%-6.17%-6.17%—
90d2+50.00%-0.72%+7.69%-8.41%-8.41%—
180d2+0.00%+13.38%+17.43%-4.05%-4.05%—
1y2+50.00%+13.50%+18.96%-5.46%-5.46%—
2y2(1 pending)+0.00%+24.26%+43.87%-19.61%-19.61%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EHC · 75,041 shares · as of Aug 10, 2026
024,89649,79274,68899,584202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 21 buys / 32 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
8,906$125.95$1.12M75,041Aug 10, 2026Aug 11, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
5,967$108.06$644.8K5,967Mar 2, 2026Mar 3, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
416$107.88$44.9K83,947Feb 28, 2026Mar 3, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
6,990$106.15$742.0K84,363Feb 23, 2026Feb 25, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
328$106.55$34.9K91,353Feb 20, 2026Feb 23, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
7,903$107.15$846.8K91,681Feb 19, 2026Feb 23, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
2,154——99,584Feb 19, 2026Feb 20, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
17,720——97,430Feb 18, 2026Feb 20, 2026 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASE
EVP, Gen Counsel & Secretary
10,000$35.06$350.6K89,710Apr 29, 2025Apr 30, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
10,000$114.79$1.15M79,710Apr 29, 2025Apr 30, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
10,000——4,858Apr 29, 2025Apr 30, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
6,032$98.45$593.9K6,032Mar 4, 2025Mar 5, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
416$100.14$41.7K79,710Feb 28, 2025Mar 3, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
509$100.63$51.2K80,126Feb 25, 2025Feb 26, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
437$97.53$42.6K80,635Feb 24, 2025Feb 26, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
2,216——81,072Feb 20, 2025Feb 21, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
5,917$92.35$546.4K78,856Jan 1, 2025Jan 3, 2025 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
14,543——0May 6, 2024May 7, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
14,543$83.94$1.22M84,773May 6, 2024May 7, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASE
EVP, Gen Counsel & Secretary
14,543$29.06$422.6K99,316May 6, 2024May 7, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
13,116——81,961Feb 28, 2024Feb 29, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
2,812——84,773Feb 28, 2024Feb 29, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
509$75.25$38.3K68,845Feb 25, 2024Feb 26, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
397$75.25$29.9K69,354Feb 24, 2024Feb 26, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
437$75.25$32.9K69,751Feb 23, 2024Feb 26, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
4,920$66.72$328.3K70,188Jan 2, 2024Jan 3, 2024 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
8,689——8,689Mar 1, 2023Mar 2, 2023 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
509$60.22$30.7K75,108Feb 27, 2023Feb 27, 2023 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
397$60.22$23.9K75,617Feb 24, 2023Feb 27, 2023 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
17,728——76,014Feb 23, 2023Feb 23, 2023 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
10,799——58,286Feb 23, 2023Feb 23, 2023 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
369$62.86$23.2K47,487Feb 21, 2023Feb 21, 2023 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
3,113$59.81$186.2K47,856Jan 3, 2023Jan 4, 2023 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
10,715——10,715Mar 1, 2022Mar 2, 2022 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
5,572——48,800Feb 25, 2022Feb 25, 2022 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
2,854——43,228Feb 25, 2022Feb 25, 2022 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
330$65.52$21.6K40,374Feb 24, 2022Feb 25, 2022 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
673$65.91$44.4K40,704Feb 22, 2022Feb 23, 2022 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
2,537$65.26$165.6K41,377Jan 3, 2022Jan 5, 2022 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
9,375——9,375Mar 2, 2021Mar 3, 2021 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
2,224——43,914Feb 24, 2021Feb 25, 2021 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
5,466——41,690Feb 24, 2021Feb 25, 2021 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
401$80.23$32.2K36,224Feb 23, 2021Feb 25, 2021 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
366$80.51$29.5K36,625Feb 21, 2021Feb 23, 2021 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
305$80.51$24.6K36,991Feb 20, 2021Feb 23, 2021 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
5,058$82.69$418.2K37,296Jan 4, 2021Jan 5, 2021 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
9,718——9,718Mar 2, 2020Mar 3, 2020 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
402$81.64$32.8K42,354Feb 24, 2020Feb 25, 2020 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
366$81.64$29.9K42,756Feb 21, 2020Feb 25, 2020 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
11,304——41,052Feb 20, 2020Feb 20, 2020 ↗View →
EHC
ENCOMPASS HEALTH CORP
PURCHASEGRANT
Stock grant
2,070——43,122Feb 20, 2020Feb 20, 2020 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
528$82.61$43.6K29,748Feb 18, 2020Feb 20, 2020 ↗View →
EHC
ENCOMPASS HEALTH CORP
SALE
EVP, Gen Counsel & Secretary
6,029$69.27$417.6K30,276Jan 2, 2020Jan 3, 2020 ↗View →
Other insiders · EHC
Loading peer insiders…
About this filer
CIK 0001664699
ROLE
EVP, Gen Counsel & Secretary
PRIMARY
EHC
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001664699DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback